companiesCompany
biolitec
biolitec is a German medical laser company that holds the EU authorisation for temoporfin (Foscan), a photosensitiser for palliative photodynamic therapy of advanced head and neck cancer.
Overview
biolitec pharma markets Foscan (temoporfin), authorised in the EU in 2001 for palliative treatment of advanced head and neck squamous cell carcinoma that has failed prior therapy and is unsuitable for radiotherapy, surgery or systemic chemotherapy, alongside its laser systems.
Headquarters
Jena, DE
Scorecard
All companies#150of 680 companies, score 13
- approved products +6
- modalities +2
- regions +1
- registry trials +4
1 approved, 0 in phase 3, 0 earlier, 0 targets, 5 registry studies. Formula on the scorecards page.
Type
devices
Website